STOCK TITAN

[Form 4] COLGATE PALMOLIVE CO Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Lorrie M. Norrington, a director of Colgate-Palmolive Company (CL), reported a transaction dated 10/01/2025 in which she acquired 319 shares of Colgate common stock at a price of $82.13 per share. After this transaction she beneficially owned 39,061 shares in a direct ownership form. The filing states the purchase reflects a portion of an annual cash retainer deferred into a stock unit account under the company’s Deferred Compensation Plan for Non-Employee Directors. The Form 4 was signed by an attorney-in-fact on 10/03/2025.

Lorrie M. Norrington, una regista direttrice della Colgate-Palmolive Company (CL), ha riportato una transazione datata 10/01/2025 in cui ha acquisito 319 azioni delle azioni ordinarie Colgate a un prezzo di $82.13 per azione. Dopo questa operazione possedeva beneficiariamente 39.061 azioni in una forma di proprietà diretta. Il fascicolo indica che l'acquisto riflette una porzione di un compenso annuale in contanti differito in un conto unità azioni ai sensi del piano di compensazione differita per i direttori non dipendenti dell'azienda. Il Modulo 4 è stato firmato da un procuratore il 10/03/2025.

Lorrie M. Norrington, una directora de la Colgate-Palmolive Company (CL), informó una transacción fechada el 10/01/2025 en la que adquirió 319 acciones de las acciones ordinarias de Colgate a un precio de $82.13 por acción. Después de esta operación poseía beneficiosamente 39,061 acciones en una forma de propiedad directa. La presentación indica que la compra refleja una porción de un complemento anual en efectivo diferido en una cuenta de unidades de acciones bajo el plan de compensación diferida para directores no empleados de la empresa. El Formulario 4 fue firmado por un apoderado el 10/03/2025.

로리 M. 노링턴, Colgate-Palmolive Company(CL)의 이사로서, 10/01/2025자로 거래를 보고했고 그 거래에서 Colgate 보통주 319주를 주당 $82.13에 취득했습니다. 이 거래 이후 그녀는 직접 소유 형태로 39,061주를 실제로 소유하게 되었습니다. 제출서는 매수가 회사의 비상임 이사들을 위한 이연 보상계획에 따라 현금 보상을 매년 일부를 주식단위 계좌로 이연한 것을 반영한다고 명시합니다. Form 4는 2025년 10/03/2025에 대리인이 서명했습니다.

Lorrie M. Norrington, une directrice de la Colgate-Palmolive Company (CL), a signalé une transaction datée du 01/10/2025 dans laquelle elle a acquis 319 actions ordinaires de Colgate au prix de 82,13 $ par action. Après cette transaction, elle détenait 39 061 actions en une forme de propriété directe. Le dossier indique que l'achat reflète une partie d'un revenu annuel en espèces différé dans un compte d'unités d'actions en vertu du plan de rémunération différée pour les administrateurs non salariés de l'entreprise. Le Formulaire 4 a été signé par un mandataire le 03/10/2025.

Lorrie M. Norrington, eine Direktorin der Colgate-Palmolive Company (CL), berichtete eine Transaktion datiert auf 01.10.2025, bei der sie 319 Stammaktien von Colgate zu einem Preis von 82,13 $ pro Aktie erworben hat. Nach dieser Transaktion besaß sie in einer direkten Eigentümerschaftsform 39.061 Aktien. Die Einreichung besagt, dass der Kauf eine Portion eines jährlichen Barretainers widerspiegelt, der in ein Aktien-Einheitenkonto gemäß dem Deferred Compensation Plan for Non-Employee Directors des Unternehmens verschoben wurde. Das Formular 4 wurde von einem Bevollmächtigten am 03.10.2025 unterzeichnet.

لوري م. نورينغتون، مديرة في شركة Colgate-Palmolive (CL)، أبلغت عن صفقة بتاريخ 01/10/2025 قامت خلالها بـ شراء 319 سهماً من أسهم Colgate العادية بسعر $82.13 للسهم. بعد هذه الصفقة كانت تملك 39,061 سهماً بشكل مباشر بما يعكس الملكية المباشرة. ويفيد الملف أن الشراء يعكس جزءاً من بدل نقدي سنوي مؤجل إلى حساب وحدات الأسهم بموجب خطة التعويض المؤجل لمديري الشركة غير الموظفين. وتم توقيع النموذج 4 من قبل وكيل قانوني في التاريخ 10/03/2025.

洛里·M·诺灵顿,科尔盖特-帕尔默菲公司(CL)的一位董事,报告了一笔日期为 2025/10/01 的交易,她以每股 $82.13 的价格购买了 319 股科尔盖特普通股。此次交易后,她以直接所有权形式实际拥有 39,061 股。该备案称该购买反映了将年度现金保留金的一部分递延至公司为非员工董事设立的股票单位账户的安排。Form 4 已由授权代理人于 2025/10/03 签署。

Positive
  • None.
Negative
  • None.

Lorrie M. Norrington, una regista direttrice della Colgate-Palmolive Company (CL), ha riportato una transazione datata 10/01/2025 in cui ha acquisito 319 azioni delle azioni ordinarie Colgate a un prezzo di $82.13 per azione. Dopo questa operazione possedeva beneficiariamente 39.061 azioni in una forma di proprietà diretta. Il fascicolo indica che l'acquisto riflette una porzione di un compenso annuale in contanti differito in un conto unità azioni ai sensi del piano di compensazione differita per i direttori non dipendenti dell'azienda. Il Modulo 4 è stato firmato da un procuratore il 10/03/2025.

Lorrie M. Norrington, una directora de la Colgate-Palmolive Company (CL), informó una transacción fechada el 10/01/2025 en la que adquirió 319 acciones de las acciones ordinarias de Colgate a un precio de $82.13 por acción. Después de esta operación poseía beneficiosamente 39,061 acciones en una forma de propiedad directa. La presentación indica que la compra refleja una porción de un complemento anual en efectivo diferido en una cuenta de unidades de acciones bajo el plan de compensación diferida para directores no empleados de la empresa. El Formulario 4 fue firmado por un apoderado el 10/03/2025.

로리 M. 노링턴, Colgate-Palmolive Company(CL)의 이사로서, 10/01/2025자로 거래를 보고했고 그 거래에서 Colgate 보통주 319주를 주당 $82.13에 취득했습니다. 이 거래 이후 그녀는 직접 소유 형태로 39,061주를 실제로 소유하게 되었습니다. 제출서는 매수가 회사의 비상임 이사들을 위한 이연 보상계획에 따라 현금 보상을 매년 일부를 주식단위 계좌로 이연한 것을 반영한다고 명시합니다. Form 4는 2025년 10/03/2025에 대리인이 서명했습니다.

Lorrie M. Norrington, une directrice de la Colgate-Palmolive Company (CL), a signalé une transaction datée du 01/10/2025 dans laquelle elle a acquis 319 actions ordinaires de Colgate au prix de 82,13 $ par action. Après cette transaction, elle détenait 39 061 actions en une forme de propriété directe. Le dossier indique que l'achat reflète une partie d'un revenu annuel en espèces différé dans un compte d'unités d'actions en vertu du plan de rémunération différée pour les administrateurs non salariés de l'entreprise. Le Formulaire 4 a été signé par un mandataire le 03/10/2025.

Lorrie M. Norrington, eine Direktorin der Colgate-Palmolive Company (CL), berichtete eine Transaktion datiert auf 01.10.2025, bei der sie 319 Stammaktien von Colgate zu einem Preis von 82,13 $ pro Aktie erworben hat. Nach dieser Transaktion besaß sie in einer direkten Eigentümerschaftsform 39.061 Aktien. Die Einreichung besagt, dass der Kauf eine Portion eines jährlichen Barretainers widerspiegelt, der in ein Aktien-Einheitenkonto gemäß dem Deferred Compensation Plan for Non-Employee Directors des Unternehmens verschoben wurde. Das Formular 4 wurde von einem Bevollmächtigten am 03.10.2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
NORRINGTON LORRIE M

(Last) (First) (Middle)
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE

(Street)
NEW YORK NY 10022

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2025 A(1) 319 A $82.13 39,061 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.
/s/ Kristine Hutchinson, Attorney-in-Fact 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Colgate-Palmolive director Lorrie Norrington report (CL)?

The Form 4 reports that Lorrie M. Norrington acquired 319 shares of Colgate common stock on 10/01/2025 at $82.13 per share.

How many Colgate shares does Lorrie Norrington own after the transaction?

Following the reported transaction, she beneficially owned 39,061 shares in a direct ownership form.

Why were the shares acquired according to the filing?

The filing explains the shares reflect a portion of the annual cash retainer deferred into a stock unit account under the Deferred Compensation Plan for Non-Employee Directors.

When was the Form 4 signed and by whom?

The Form 4 bears a signature by an attorney-in-fact, Kristine Hutchinson, dated 10/03/2025.

What was the transaction price per share in the Form 4?

The reported transaction price was $82.13 per share.
Colgate Palmolive Co

NYSE:CL

CL Rankings

CL Latest News

CL Latest SEC Filings

CL Stock Data

63.29B
806.85M
0.16%
86.07%
1.44%
Household & Personal Products
Perfumes, Cosmetics & Other Toilet Preparations
Link
United States
NEW YORK